Discovery of Heart Protein AIMP3 Highlights New Target for Cardiac Disease Treatments
Brown University researchers have uncovered the vital role of the protein AIMP3 in heart health, opening new possibilities for cardiac disease treatment by targeting this molecular mechanism.
Recent research conducted by molecular biologists at Brown University has identified a critical role for the protein AIMP3 in maintaining heart health. Published in Nature Cardiovascular Research, the study reveals that AIMP3 is essential for proper heart function and survival. The team used gene editing techniques to delete AIMP3 in mice, leading to severe cardiac issues such as inflammation, tissue scarring, and ultimately, heart failure.
Initially, AIMP3 was an unstudied protein with an unclear function within the heart. However, findings from the study demonstrate that AIMP3 is vital for preventing errors during protein synthesis in cardiac cells. It acts by supporting the editing activity of MetRS, a protein responsible for removing harmful substances like homocysteine. Without AIMP3, homocysteine accumulates, causing oxidative stress, protein aggregation, and mitochondrial defects, which lead to cell death.
The research team, led by postdoctoral researcher Anindhya S. Das, showed that deficiency of AIMP3 results in significant damage to heart cells and the development of severe cardiac diseases. They believe this protein has a broader role in other organs, given that it influences cellular health beyond the heart.
Understanding the mechanisms behind AIMP3’s protective effects opens new avenues for treating heart conditions associated with homocysteine buildup. Future studies aim to explore ways to boost AIMP3 levels or enhance its activity to prevent or treat heart disease. As cardiovascular disease remains the leading cause of death globally, this discovery marks an important step towards innovative therapeutic strategies.
Further details can be found in the original study here: Nature Cardiovascular Research.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
The Impact of Federal Funding on Developing Breakthrough Medicines
Federal funding significantly contributes to the development of life-changing medicines, with over half of recent FDA-approved drugs linked to NIH-backed research, emphasizing the importance of sustained investment in biomedical sciences.
Groundbreaking Achievement: First Successful Human Bladder Transplant Performed in the U.S.
Surgeons at UCLA have successfully performed the world's first human bladder transplant, providing new hope for patients with severe bladder conditions.
The Lancet Calls for Embracing One Health: A Global Policy Shift for a Healthier Future
The Lancet Commission urges a global policy overhaul by adopting the One Health approach to tackle interconnected health crises such as zoonoses, antimicrobial resistance, and climate change for a sustainable, healthier future.
GLP-1 Receptor Agonists Associated with Reduced Mortality in Elderly Cancer Patients with T2D
A recent study shows that GLP-1 receptor agonists are associated with lower mortality rates in elderly cancer patients with type 2 diabetes, offering promising survival benefits in this vulnerable population.